KR0169501B1 - 아닐리드 유도체 - Google Patents

아닐리드 유도체 Download PDF

Info

Publication number
KR0169501B1
KR0169501B1 KR1019930701531A KR930701531A KR0169501B1 KR 0169501 B1 KR0169501 B1 KR 0169501B1 KR 1019930701531 A KR1019930701531 A KR 1019930701531A KR 930701531 A KR930701531 A KR 930701531A KR 0169501 B1 KR0169501 B1 KR 0169501B1
Authority
KR
South Korea
Prior art keywords
group
compound
carbon atoms
diisopropylphenyl
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930701531A
Other languages
English (en)
Korean (ko)
Other versions
KR930702254A (ko
Inventor
마사카즈 사토
유타카 카와시마
카츠오 하타야마
Original Assignee
우에하라 아키라
다이쇼 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우에하라 아키라, 다이쇼 세이야꾸 가부시끼가이샤 filed Critical 우에하라 아키라
Publication of KR930702254A publication Critical patent/KR930702254A/ko
Application granted granted Critical
Publication of KR0169501B1 publication Critical patent/KR0169501B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/32Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1019930701531A 1990-11-26 1991-11-21 아닐리드 유도체 Expired - Fee Related KR0169501B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP90-322136 1990-11-26
JP322136/1990 1990-11-26
JP32213690 1990-11-26
PCT/JP1991/001602 WO1992009572A1 (en) 1990-11-26 1991-11-21 Anilide derivative

Publications (2)

Publication Number Publication Date
KR930702254A KR930702254A (ko) 1993-09-08
KR0169501B1 true KR0169501B1 (ko) 1999-03-20

Family

ID=18140332

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930701531A Expired - Fee Related KR0169501B1 (ko) 1990-11-26 1991-11-21 아닐리드 유도체

Country Status (11)

Country Link
US (1) US5475130A (enExample)
EP (1) EP0559898B1 (enExample)
JP (1) JP2650096B2 (enExample)
KR (1) KR0169501B1 (enExample)
AT (1) ATE137744T1 (enExample)
CA (1) CA2096970C (enExample)
DE (1) DE69119434T2 (enExample)
DK (1) DK0559898T3 (enExample)
ES (1) ES2088574T3 (enExample)
GR (1) GR3020257T3 (enExample)
WO (1) WO1992009572A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
WO1994002452A1 (fr) * 1992-07-20 1994-02-03 Eisai Co., Ltd. Derive du benzene
WO1995014463A1 (en) * 1993-11-25 1995-06-01 Taisho Pharmaceutical Co., Ltd. Composition of pharmaceutical preparation improved in peroral absorbability
FR2729665B1 (fr) * 1995-01-19 1997-04-18 Pf Medicament Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
CA2285374A1 (en) * 1997-04-01 1998-10-08 Taisho Pharmaceutical Co., Ltd. Preventives for reconstriction
KR20010005845A (ko) * 1997-04-01 2001-01-15 우에하라 아끼라 허혈성 심장 질환 예방제
WO2003020315A1 (fr) * 2001-08-28 2003-03-13 Sankyo Company, Limited Compositions medicinales contenant un antagoniste du recepteur d'angiotensine ii
US20050119314A1 (en) * 2002-04-05 2005-06-02 Sankyo Company, Limited Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
MX2007005129A (es) * 2004-10-27 2007-09-11 Daiichi Sankyo Co Ltd Compuesto de benceno que tiene 2 o mas sustituyentes.
CA2657247A1 (en) * 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
WO2008039645A1 (en) * 2006-09-25 2008-04-03 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
CA2704684A1 (en) * 2007-11-07 2009-05-14 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
CA2730037A1 (en) * 2008-07-10 2010-01-14 Boehringer Ingelheim International Gmbh Sulfone compounds which modulate the cb2 receptor
KR20110063485A (ko) * 2008-09-25 2011-06-10 베링거 인겔하임 인터내셔날 게엠베하 Cb2 수용체를 선택적으로 조절하는 설포닐 화합물
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
JP5756800B2 (ja) 2009-06-16 2015-07-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を調節するアゼチジン2−カルボキサミド誘導体
WO2011037795A1 (en) * 2009-09-22 2011-03-31 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
WO2011088015A1 (en) 2010-01-15 2011-07-21 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
JP5746228B2 (ja) 2010-03-05 2015-07-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を選択的に調節するテトラゾール化合物
US8846936B2 (en) 2010-07-22 2014-09-30 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the CB2 receptor
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878248A (en) * 1971-05-03 1975-04-15 Monsanto Co Substituted alpha, alpha-dichloro-methane-sulfenyl chlorides
JPS5439028A (en) * 1977-08-31 1979-03-24 Hokko Chem Ind Co Ltd Acetanilide derivatives and bactericides containing the same for agricultural and horticultural, uses
US4329363A (en) * 1978-09-08 1982-05-11 Merck & Co., Inc. Substituted mercapto acid amides and their use
US4623662A (en) * 1985-05-23 1986-11-18 American Cyanamid Company Antiatherosclerotic ureas and thioureas
FR2540495B1 (fr) * 1983-02-07 1986-02-14 Roussel Uclaf Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
GB2149394B (en) * 1983-07-19 1986-09-24 American Cyanamid Co Ureas
US4859707A (en) * 1983-08-23 1989-08-22 Key Pharmaceuticals, Inc. Sulfur-substituted phenylacetamides
AU584669B2 (en) * 1985-02-04 1989-06-01 G.D. Searle & Co. Novel disubstituted 4-hydroxyphenylthio anilides
ZA871597B (en) * 1986-03-24 1988-10-26 Warner Lambert Co Substituted anilides of oleic,linoleic,or linolenic acid as inhibitors of acyl-coa:cholestrol acyltransferase
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
EP0361365A1 (en) * 1988-09-30 1990-04-04 E.R. SQUIBB & SONS, INC. Aminobenzoic and aminocyclohexane-carboylic acid compounds, compositions, and their method of use
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)

Also Published As

Publication number Publication date
DE69119434T2 (de) 1996-09-12
CA2096970A1 (en) 1992-05-27
DK0559898T3 (da) 1996-08-19
EP0559898A4 (enExample) 1994-01-12
JP2650096B2 (ja) 1997-09-03
KR930702254A (ko) 1993-09-08
US5475130A (en) 1995-12-12
ATE137744T1 (de) 1996-05-15
ES2088574T3 (es) 1996-08-16
WO1992009572A1 (en) 1992-06-11
DE69119434D1 (de) 1996-06-13
GR3020257T3 (en) 1996-09-30
EP0559898A1 (en) 1993-09-15
CA2096970C (en) 1998-07-14
EP0559898B1 (en) 1996-05-08

Similar Documents

Publication Publication Date Title
KR0169501B1 (ko) 아닐리드 유도체
US4980372A (en) Benzoylaminophenoxybutanoic acid derivatives
JP2943089B2 (ja) イソプレノイドホスホリパーゼ▲a2▼阻害剤およびそれを包含する製剤
HUP0202731A2 (hu) o-Ánizsamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
US4983624A (en) Novel prolinal derivatives
US4370340A (en) Benzothiazol-2-one-3-alkanoic acids and esters and aldose reductase inhibiting compositions thereof
JP2004511456A (ja) 糖尿病用薬剤
US4670469A (en) Hydroxamic acid and pharmaceutical preparations containing the same
CA2123267A1 (fr) Indoles substitues leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5262431A (en) Prolinal derivatives and pharmaceutical compositions thereof
US5475021A (en) Compounds and compositions for inhibition of cyclooxygenase activity
JPH0460103B2 (enExample)
GB2038838A (en) Immunogen conjugates of diphenyldantoin
US4175130A (en) Oxazole- and thiazole-alkanoic acid compounds
JP2842147B2 (ja) Acat阻害剤
US4091097A (en) Treatment of elevated histamine and uric acid levels
EP0121806B1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
US5665749A (en) Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
BE1008216A4 (fr) Derives chemoluminescents heterocycliques.
FR2597865A1 (fr) Nouveaux derives d'un acide benzyl alkyl carboxylique substitue par un radical 4-pyridinyl aminocarbonyle, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
JPH04173775A (ja) アニリド誘導体
EP0035903B1 (en) Dibenzocycloheptenylidenes and their use in pharmaceutical compositions
EP0002401B1 (fr) Dérivés de naphtalène, leur préparation et leur application en thérapeutique
JP3220225B2 (ja) グアニジノフェノール誘導体
FR2673629A1 (fr) Nouveaux derives du benzopyrane leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20021008

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20031013

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20031013

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000